PTPN6
Tyrosine-protein phosphatase non-receptor type 6
Also known as: HCP, HCPH, PTN6_HUMAN, PTP-1C, SHP-1, SHP1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P29350
- Gene
- PTPN6
- Ensembl
- ENSG00000111679
- Chromosome
- 12
- Canonical length
- 595 aa
- Protein class
- Enzymes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli
OverviewNCBI Gene
The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. N-terminal part of this PTP contains two tandem Src homolog (SH2) domains, which act as protein phospho-tyrosine binding domains, and mediate the interaction of this PTP with its substrates. This PTP is expressed primarily in hematopoietic cells, and functions as an important regulator of multiple signaling pathways in hematopoietic cells. This PTP has been shown to interact with, and dephosphorylate a wide spectrum of phospho-proteins involved in hematopoietic cell signaling. Multiple alternatively spliced variants of this gene, which encode distinct isoforms, have been reported. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
595 residues, UniProt reviewed canonical sequence.
>P29350|PTPN6
1 MVRWFHRDLS GLDAETLLKG RGVHGSFLAR PSRKNQGDFS LSVRVGDQVT HIRIQNSGDF
61 YDLYGGEKFA TLTELVEYYT QQQGVLQDRD GTIIHLKYPL NCSDPTSERW YHGHMSGGQA
121 ETLLQAKGEP WTFLVRESLS QPGDFVLSVL SDQPKAGPGS PLRVTHIKVM CEGGRYTVGG
181 LETFDSLTDL VEHFKKTGIE EASGAFVYLR QPYYATRVNA ADIENRVLEL NKKQESEDTA
241 KAGFWEEFES LQKQEVKNLH QRLEGQRPEN KGKNRYKNIL PFDHSRVILQ GRDSNIPGSD
301 YINANYIKNQ LLGPDENAKT YIASQGCLEA TVNDFWQMAW QENSRVIVMT TREVEKGRNK
361 CVPYWPEVGM QRAYGPYSVT NCGEHDTTEY KLRTLQVSPL DNGDLIREIW HYQYLSWPDH
421 GVPSEPGGVL SFLDQINQRQ ESLPHAGPII VHCSAGIGRT GTIIVIDMLM ENISTKGLDC
481 DIDIQKTIQM VRAQRSGMVQ TEAQYKFIYV AIAQFIETTK KKLEVLQSQK GQESEYGNIT
541 YPPAMKNAHA KASRTSSKHK EDVYENLHTK NKREEKVKKQ RSADKEKSKG SLKRKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PTPN6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 144 nTPM
Expression across tissuesHPA
Tissue
- lymph node: 144 nTPM
- spleen: 128 nTPM
- bone marrow: 125 nTPM
- tonsil: 119 nTPM
- appendix: 97 nTPM
- thymus: 67 nTPM
Single-cell type
- tuft cells: 404 nCPM
- neutrophils: 361 nCPM
- hofbauer cells: 268 nCPM
- neutrophil progenitors: 210 nCPM
- monocytes: 173 nCPM
- megakaryocytes: 167 nCPM
Immune cell
- non-classical monocyte: 1,122 nTPM
- eosinophil: 1,115 nTPM
- total PBMC: 788 nTPM
- intermediate monocyte: 728 nTPM
- basophil: 678 nTPM
- neutrophil: 677 nTPM
Brain region
- white matter: 20 nTPM
- medulla oblongata: 12 nTPM
- thalamus: 11 nTPM
- spinal cord: 10 nTPM
- choroid plexus: 10 nTPM
- pons: 9.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.13
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.87
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- B cell receptor signaling pathway
- CD27 signaling pathway
- cell differentiation
- cytokine-mediated signaling pathway
- epididymis development
- G protein-coupled receptor signaling pathway
- hematopoietic progenitor cell differentiation
- MAPK cascade
- megakaryocyte development
- mitotic cell cycle
- natural killer cell mediated cytotoxicity
- negative regulation of angiogenesis
- negative regulation of B cell receptor signaling pathway
- negative regulation of cell population proliferation
- negative regulation of humoral immune response mediated by circulating immunoglobulin
- negative regulation of inflammatory response to wounding
- negative regulation of innate immune response
- negative regulation of interleukin-6 production
- negative regulation of lipopolysaccharide-mediated signaling pathway
- negative regulation of MAPK cascade
- negative regulation of mast cell activation involved in immune response
- negative regulation of neutrophil activation
- negative regulation of T cell proliferation
- negative regulation of T cell receptor signaling pathway
- negative regulation of tumor necrosis factor production
- peptidyl-tyrosine dephosphorylation
- peptidyl-tyrosine phosphorylation
- platelet aggregation
- platelet formation
- positive regulation of cell adhesion mediated by integrin
- positive regulation of cell population proliferation
- positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- protein dephosphorylation
- regulation of apoptotic process
- regulation of B cell differentiation
- regulation of ERK1 and ERK2 cascade
- regulation of G1/S transition of mitotic cell cycle
- regulation of release of sequestered calcium ion into cytosol
- regulation of type I interferon-mediated signaling pathway
- T cell activation
- T cell costimulation
- T cell proliferation
- T cell receptor signaling pathway
Molecular functions
- cell adhesion molecule binding
- non-membrane spanning protein tyrosine phosphatase activity
- phosphorylation-dependent protein binding
- phosphotyrosine residue binding
- protein kinase binding
- protein tyrosine phosphatase activity
- SH2 domain binding
- SH3 domain binding
- transmembrane receptor protein tyrosine phosphatase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Tyrosine-specific protein phosphatase, PTPase domain
- Tyrosine-specific protein phosphatases domain
- SH2 domain
- Protein-tyrosine phosphatase, catalytic
- Protein-tyrosine phosphatase, non-receptor type-6, -11
- Protein-tyrosine phosphatase, active site
- Protein-tyrosine phosphatase-like
- SH2 domain superfamily
- SH2 domain
- Protein-tyrosine phosphatase
- Non-receptor Tyrosine Phosphatase
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PTPN6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PTPN6 as an antibody target. Whether an autoantibody or antibody against PTPN6 could matter depends on whether native PTPN6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PTPN6 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PTPN6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...